We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us
IBA-Radcal

Download Mobile App




Resorbable Implants for Craniofacial Surgery

By HospiMedica staff writers
Posted on 06 Aug 2001
Resorbable implants are effective for craniofacial surgery and offer important advantages over titanium devices, including reduced surgical time, greater simplicity and ease of use, and a much less invasive follow-up procedure.

The titanium modular distraction system invented by Dr. More...
Steven R. Cohen, M.D., has now been redesigned to eliminate its disadvantages. The titanium plates and screws used were hard to remove after completion of the distraction procedure. Dr. Cohen worked closely with Dr. Ralph E. Holmes and a team at Macropore, Inc. (San Diego, CA, USA) to create a resorbable design. This eliminated the need for total surgical re-exposure to remove metallic components. The new implants are made from a medical grade 100% amorphous polylactic acid copolymer that retains around 70% of its initial strength after nine months and 50% after 12 months. The implants ultimately metabolize into carbon dioxide and water following a process of bulk hydrolysis and then resorb completely in about 18-36 months.

Recently Drs. Cohen and Holmes performed the first internal LeFort III distraction using the new resorbable distraction system. "Before the development of the biodegradable device, LeFort III distraction patients spent long periods of time in external or internal metal devices,” noted Dr. Cohen.




Related Links:
Macropore

Gold Member
12-Channel ECG
CM1200B
Antipsychotic TDM Assays
Saladax Antipsychotic Assays
Absorbable Monofilament Mesh
Phasix Mesh
Pressure Guidewire
SavvyWire
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to HospiMedica.com and get access to news and events that shape the world of Hospital Medicine.
  • Free digital version edition of HospiMedica International sent by email on regular basis
  • Free print version of HospiMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of HospiMedica International in digital format
  • Free HospiMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








Channels

Patient Care

view channel
Image: The revolutionary automatic IV-Line flushing device set for launch in the EU and US in 2026 (Photo courtesy of Droplet IV)

Revolutionary Automatic IV-Line Flushing Device to Enhance Infusion Care

More than 80% of in-hospital patients receive intravenous (IV) therapy. Every dose of IV medicine delivered in a small volume (<250 mL) infusion bag should be followed by subsequent flushing to ensure... Read more

Business

view channel
Image: Medtronic’s intent to acquire CathWorks follows a 2022 strategic partnership with a co-promotion agreement for the FFRangio System (Photo courtesy of CathWorks)

Medtronic to Acquire Coronary Artery Medtech Company CathWorks

Medtronic plc (Galway, Ireland) has announced that it will exercise its option to acquire CathWorks (Kfar Saba, Israel), a privately held medical device company, which aims to transform how coronary artery... Read more
Copyright © 2000-2026 Globetech Media. All rights reserved.